We introduce a next phase in the evolution of medicine affecting human and veterinary patients. This evolution, genomic cancer medicine (Pmed), involves expansion of genomic and molecular biology into clinical medicine. The implementation of these new technologies has already begun and is a commercial reality. We introduce the underpinnings for this evolution, and focus on application in complex disease states. Pet owners have begun requesting Pmed technologies. To meet this demand, it is important to be aware of the opportunities and obstacles associated with available Pmed offerings as well as the current state of the field.

中文翻译：

---

致力于精确兽医学医学的交付。

我们介绍了影响人类和兽医患者的药物发展的下一阶段。这种进化，即基因组癌症医学（Pmed），涉及将基因组和分子生物学扩展到临床医学。这些新技术的实施已经开始并且是商业现实。我们介绍了这种进化的基础，并着重于在复杂疾病状态下的应用。宠物主人已经开始要求Pmed技术。为了满足这一需求，重要的是要意识到与可用的Pmed产品相关的机遇和障碍以及该领域的当前状况。